osaühing NURME APTEEK

Active Registry code 10046931 OÜ Haapsalu linn Registered 20 Jun 1996

osaühing NURME APTEEK is a OÜ based in Haapsalu linn, registry code 10046931, status: active. Main activity: Retail sale of pharmaceutical products. According to EMTA, turnover for Q3 2026 was €1 065 101 with 11 employees.

Turnover

1 065 101 €

↓ 1.9% vs Q2 2026

State taxes

31 632 €

↓ 31.4% vs Q2 2026

Labour taxes

28 281 €

↑ 14.3% vs Q2 2026

Employees

+1 vs Q2 2026

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Retail trade · EMTAK 47

Turnover · Q3 2026 1.1 mn €

above 98% of companies

industry median 23 652 € · companies in the industry: 7 652
Labour taxes per employee 2 571 €

above 84% of companies

industry median 1 201 € · companies in the industry: 4 663
Revenue · 2025 3.9 mn €

above 98% of companies

industry median 16 974 € · companies in the industry: 13 500
Net profit margin · 2025 6.3 %

above 68% of companies

industry median 1.3 % · companies in the industry: 9 480

Taxes and turnover

Q4 2023 – Q3 2026

Turnover, € thousand Q3 2026: 1 065 101 € · −1.9% vs Q2 2026 · industry median 23 652 € · above 98% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Labour taxes per employee, € Q3 2026: 2 571 € · +3.9% vs Q2 2026 · industry median 1 201 € · above 84% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q3 2026: 11 · +10.0% vs Q2 2026

State taxes, € thousand Q3 2026: 31 632 € · −31.4% vs Q2 2026

Figures by quarter
Quarter	Turnover, €	State taxes, €	Labour taxes, €	Employees
Q3 2026	1 065 101	31 632	28 281	11
Q2 2026	1 086 208	46 142	24 738	10
Q1 2026	1 113 202	43 534	31 384	9
Q4 2025	1 144 917	99 632	27 610	9
Q3 2025	997 243	54 806	31 799	9
Q2 2025	1 036 968	43 256	31 579	12
Q1 2025	981 553	54 768	36 039	12
Q4 2024	994 843	92 722	40 133	12
Q3 2024	985 799	44 921	28 348	12
Q2 2024	890 454	50 310	30 567	12
Q1 2024	852 251	49 476	33 328	13
Q4 2023	891 292	136 291	41 128	12
Q3 2023	834 231	35 984	22 607	12
Q2 2023	802 608	37 541	23 619	11
Q1 2023	790 980	42 265	26 545	12
Q4 2022	858 815	135 664	36 415	12
Q3 2022	784 642	35 009	22 099	12
Q2 2022	758 137	37 488	21 922	12
Q1 2022	766 885	92 957	37 719	12

Labour taxes per employee per month

857 €

Turnover per employee in the quarter

96 827 €

Q3 2026 · calculated from EMTA data

Financials by year

2016 – 2025

Revenue, € thousand 2025: 3 919 154 € · +9.8% vs 2024 · industry median 16 974 € · above 98% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € thousand 2025: 246 053 € · +31.4% vs 2024 · industry median 0 € · above 98% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 6.3 % · +1.0 pp vs the year before · industry median 1.3 % · above 68% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 536 401 € · +13.0% vs 2024

Equity, € thousand 2025: 248 631 € · +30.9% vs 2024

Employees 2025: 9 · +0.0% vs 2024 · industry median 2 · above 90% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year	Revenue, €	Net profit, €	Labour costs, €	Assets, €	Equity, €	Employees
2025	3 919 154	246 053	296 651	536 401	248 631	9
2024	3 569 630	187 223	312 006	474 538	189 978	9
2023	3 145 993	188 666	271 176	503 102	211 555	8
2022	2 993 411	219 414	246 454	517 618	422 889	9
2021	2 962 739	217 729	267 182	700 608	603 475	10
2020	2 773 104	298 229	211 152	665 414	585 746	10
2019	2 597 930	207 986	209 555	586 934	437 518	11
2018	—	—	—	—	—	11
2017	—	—	—	—	—	10
2016	—	—	—	—	—	12
2015	—	—	—	—	—	12
2014	—	—	—	—	—	12
2013	—	—	—	—	—	12
2012	—	—	—	—	—	11
2011	—	—	—	—	—	11
2010	—	—	—	—	—	11
2009	—	—	—	—	—	10
2008	—	—	—	—	—	12
2007	—	—	—	—	—	10
2006	—	—	—	—	—	9
2005	—	—	—	—	—	9
2004	—	—	—	—	—	9
2003	—	—	—	—	—	9
2002	—	—	—	—	—	9
2001	—	—	—	—	—	9
2000	—	—	—	—	—	9
1999	—	—	—	—	—	9
1998	—	—	—	—	—	9
1997	—	—	—	—	—	8

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin

6.3 %

Net profit / revenue

Return on equity (ROE)

99.0 %

Net profit / equity

Return on assets (ROA)

45.9 %

Net profit / assets

Equity ratio

46.4 %

Equity / assets

Debt ratio

53.6 %

Liabilities / assets

Current ratio

1.86

Current assets / current liabilities

Revenue per employee

435 462 €

Revenue / average full-time employees

Labour cost per employee per month

2 747 €

Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister

Annual reports
Year	Period	Filed	Report	Documents
2025	1 Jan 2025 – 31 Dec 2025	30 Jun 2026	Company’s own	e-Äriregister
2024	1 Jan 2024 – 31 Dec 2024	30 Jun 2025	Company’s own	e-Äriregister
2023	1 Jan 2023 – 31 Dec 2023	24 Jun 2024	Company’s own	e-Äriregister
2022	1 Jan 2022 – 31 Dec 2022	28 Jun 2023	Company’s own	e-Äriregister
2021	1 Jan 2021 – 31 Dec 2021	30 Jun 2022	Company’s own	e-Äriregister
2020	1 Jan 2020 – 31 Dec 2020	18 Jun 2021	Company’s own	e-Äriregister
2019	1 Jan 2019 – 31 Dec 2019	31 Oct 2020	Company’s own	e-Äriregister

Board

Tiiu Vaha
Board member (manager) · since 2 Jan 2006
Arvo Kallasmaa
Board member · since 2 Jan 2006
Nasdaq CSD SE
Keeper of the share register · since 28 Sep 2017

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Omanikukonto: TIIU VAHA
Natural person · 1 304 €

51.02%
Omanikukonto: ARVO KALLASMAA
Natural person · 1 252 €

48.98%

Beneficial owners

Arvo Kallasmaa
Direct ownership · since 22 Oct 2018
Tiiu Vaha
Direct ownership · since 22 Oct 2018

Founders and other persons

No other persons.

shared board members, owners or beneficial owners

Activities (EMTAK)

47731Retail sale of pharmaceutical products Main

Rulings 11

All rulings (PDF)

Rulings
Number, date	Title	State	Document
Ä 30024488 / 10 25 Jun 2024	Amendment under Code of Civil Procedure § 595¹ (1)	In force 25 Jun 2024	PDF
Ä 30024488 / 9 18 Jan 2018	Amendment entry	In force 18 Jan 2018	PDF
Ä 30024488 / 8 6 Dec 2017	Amendment entry	In force 6 Dec 2017	PDF
Ä 30024488 / 7 4 Dec 2017	Amendment entry	In force 4 Dec 2017	PDF
Ä 30024488 / 6 28 Sep 2017	Amendment entry	In force 28 Sep 2017	PDF
Ä 30024488 / 5 12 Apr 2012	Amendment under Commercial Code § 525 (2)	In force 12 Apr 2012	PDF
Ä 30024488 / 4 29 Dec 2011	Note on registration of shares in the Estonian central register of securities	In force 29 Dec 2011	PDF
Ä 30024488 / 3 16 Dec 2011	Amendment entry	In force 16 Dec 2011	PDF
Ä 24488 / 2 3 Dec 2008	Deletion of activities from the registry card	In force 4 Dec 2008	PDF
Ä 2895 / 3 2 Jan 2006	Change of registry district	Confirmed 2 Jan 2006	PDF
Ä 24488 2 Jan 2006	Change of registry district	Confirmed 2 Jan 2006	PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data

osaühing NURME APTEEK

Position in the industry Retail trade · EMTAK 47

Taxes and turnover

Financials by year

Financial ratios for 2025

Annual reports

Board

Right of representation

Owners

Beneficial owners

Founders and other persons

Related companies

Activities (EMTAK)

Rulings 11